A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...
Michael J Fox has given an honest update on how he copes with Parkinson's disease. The star is best known for playing Marty ...
Summary of findings from the study and speculations from previous research. (Nishiwaki et al., npj Parkinson's Disease, 2024) ...
Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.
University of Southern California-led researchers have discovered the structural details of a brain receptor called GPR6, ...
The presentation will highlight new findings from the ATTENTION-AD study evaluating potential benefit of oral once daily blarcamesine (ANAVEX®2-73) in early Alzheimer’s disease. The data reflect up to ...
SPR301 is a potential best-in-class gene therapy candidate that delivers a more stable, rationally engineered version of GCase, the enzyme ...
Blarcamesine’s safety profile indicates not requiring routine MRI monitoring, and the advantage of blarcamesine is that it is a small oral molecule that exerts clinical benefits on cognition and ...
A new study from a database of millions of veterans nationwide reveals a possible connection between hearing loss and ...